Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
About Us
Conferences
Videos
Webinars
Media & Press
Whitepapers
Advertising
Site Map
2022
June
22
Nucleix expands EU label for bladder cancer test
Biocartis, AstraZeneca to develop CDx for EGFR TKI treatment
Bio-Techne to acquire Namocell
Wearable device, algorithm show early detection promise
Illumina launches research test for HRD
QuidelOrtho to invest 750K in heart disease awareness
Fountain Health Insurance to cover Grail multicancer test
Page 1 of 1